NOCIL Ltd., a prominent Indian manufacturer of rubber chemicals, saw its share price lock at the 20% upper circuit limit on Monday, trading at Rs 190.70 apiece on the BSE. The significant surge followed reports that the Directorate General of Trade Remedies (DGTR) has levied a five-year anti-dumping duty on key rubber chemical imports.
Anti-Dumping Duty Targets Key Imports
The Directorate General of Trade Remedies (DGTR) has imposed a protective anti-dumping duty on Sulphenamides Accelerators originating from China, the United States, and the European Union. This duty, effective for five years, aims to safeguard domestic industries from unfairly priced imports. The Commerce Ministry had reportedly notified this duty earlier in March, according to a CNBC TV18 report.
NOCIL's Role in Rubber Chemicals
NOCIL has been a key player in India's rubber chemical sector for over four decades, offering a comprehensive range of products. The company manufactures a full line of Sulphenamides Accelerators under its 'Pilcure' brand. These additives are crucial for the rubber and tyre industries, enhancing the speed and efficiency of vulcanisation processes at lower temperatures.
Q4 Performance and Future Outlook
Despite the recent stock surge, NOCIL's Q4 financial results presented a mixed picture. The company reported a revenue of Rs 330 crore, a 3% year-on-year decline but a 5% sequential increase, largely meeting analyst expectations. However, EBITDA for the quarter stood at Rs 21 crore, falling 38% year-on-year and 22% quarter-on-quarter, missing estimates of Rs 27 crore due to elevated employee expenses and higher operating costs. EBITDA margin contracted to 6.4% from 10.1% in Q4 FY25.
Conversely, net profit for Q4 came in at Rs 17 crore, down 18% year-on-year but up 16% sequentially, surpassing Axis Securities' estimate of Rs 15 crore.
Management remains optimistic about medium-term demand across its key end-user industries. The company is targeting an EBITDA margin expansion of approximately 150 basis points over the FY26 base through strategic operating leverage, cost optimisation initiatives, and an improved product mix. New product launches and higher utilisation levels are expected to support growth momentum, with management guiding for double-digit volume growth during FY27 and FY28.